Selexipag in pregnancy and pulmonary arterial hypertension

Sweta Mohanty; Janu Mangala Kanthi; Nitu Puthenveettil; Radhamany Kunjukutty; Shine Kumar

IHJ Cardiovascular Case Reports (Jan 2023)

Selexipag in pregnancy and pulmonary arterial hypertension

Sweta Mohanty,
Janu Mangala Kanthi,
Nitu Puthenveettil,
Radhamany Kunjukutty,
Shine Kumar

Affiliations

Sweta Mohanty: Department of Pediatric Cardiology, Narayana Health, Bengaluru, India
Janu Mangala Kanthi: Department of Obstetrics and Gynecology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India
Nitu Puthenveettil: Department of Anesthesiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India
Radhamany Kunjukutty: Department of Obstetrics and Gynecology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India
Shine Kumar: Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India; Corresponding author. Pulmonary Hypertension Clinic, Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, 682041, India.

Journal volume & issue: Vol. 7, no. 1
pp. 33 – 35

Abstract

Read online

Pregnancy poses a significant maternal and foetal risk in women with pulmonary arterial hypertension (PAH). With extremely limited treatment options available, we used Selexipag in addition to tadalafil in managing a pregnancy complicated by PAH. Selexipag may be a promising add-on therapy in this unique subset.

Published in IHJ Cardiovascular Case Reports

ISSN: 2468-600X (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.journals.elsevier.com/ihj-cardiovascular-case-reports

About the journal

Abstract

Keywords